In China, a large number of patients suffer from rheumatic and immune diseases. Only by early diagnosis and standardized treatment can patients return to a comfortable life as soon as possible. To promote clinical and basic research in the field of rheumatology and immunology, improve the diagnosis and treatment level of rheumatology and immunology, enhance the diagnostic and treatment capabilities of rheumatology and immunology clinical physicians, and promote communication and cooperation between rheumatology and other multidisciplinary fields. On May 27, 2025, the Chengdu High tech Medical Association successfully held a series of meetings on rheumatism and immunology, as well as a seminar on the standardized diagnosis and treatment management of rheumatoid arthritis patients under the protection of Aisin. The conference invited renowned experts in the field of rheumatology and immunology to give a special academic report, focusing on classic cases and cutting-edge technologies in the field of rheumatology and immunology for academic discussions and exchanges. They also shared new concepts, progress, and information in the current clinical rheumatology and immunology field with fellow practitioners. Representatives attending the conference expressed that they have benefited greatly.